Idexx Laboratories Inc
Overview
Idexx Laboratories Inc is listed on Nasdaq and classified as In Vitro & In Vivo Diagnostic Substances. We have no business description beyond that classification; its SEC filings describe the business.
| Information | Status | As of |
|---|---|---|
| Detailed research report | No report | |
| Rule-based screens | Scored, on no current shortlist | 2026-10-31 |
| Valuation | Model 264.11 (-52% vs price) | 2026-10-31 |
| Chart-pattern read | No read | |
| Paper portfolio | Never held |
Scores
| Method | Score | Inputs as of | Flags |
|---|---|---|---|
| Graham Defensive | 42 | 2025-12-31 | stale input |
| Magic Formula | 63 | 2025-12-31 | stale input |
| Momentum | 35 | 2026-10-30 | |
| Insider | 0 | 2026-10-30 | |
| Buffett Quality | 82 | 2025-12-31 | stale input |
| Lynch GARP | 54 | 2025-12-31 | stale input |
| Graham Enterprising | 32 | 2025-12-31 | stale input |
| Piotroski F-Score | 89 |
Every input with its filing: full score sheet · research packet (JSON) · Markdown · SEC filings.
Valuation
264.11 -52% vs price
Range 77.61 to 332.34, 3 of 3 methods agree. A labelled model estimate, not a price target. Method.